309 related articles for article (PubMed ID: 28947527)
1. Impact of clinical pharmacists in outpatient oncology practices: A review.
Gatwood J; Gatwood K; Gabre E; Alexander M
Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies.
Maleki S; Alexander M; Fua T; Liu C; Rischin D; Lingaratnam S
J Oncol Pharm Pract; 2019 Jan; 25(1):130-139. PubMed ID: 29938594
[TBL] [Abstract][Full Text] [Related]
3. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
Umar RM; Apikoglu-Rabus S; Yumuk PF
Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy.
Nigro SC; Garwood CL; Berlie H; Irons B; Longyhore D; McFarland MS; Saseen JJ; Trewet CB
Pharmacotherapy; 2014 Jan; 34(1):96-108. PubMed ID: 24122857
[TBL] [Abstract][Full Text] [Related]
5. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study comparing interventions by oncology and non-oncology pharmacists in outpatient chemotherapy.
Kaya M; Nakamura K; Nagamine M; Suyama Y; Nakajo M; Uchida R; Hagikura K; Kanda A; Sugiyama K; Sugiyama R; Nakagaki S; Kimura M
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1371. PubMed ID: 33739629
[TBL] [Abstract][Full Text] [Related]
7. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
Arnall JR; Petro R; Patel JN; Kennedy L
J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.
Shah S; Dowell J; Greene S
Ann Pharmacother; 2006 Sep; 40(9):1527-33. PubMed ID: 16882869
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit.
Crespo A; Tyszka M
J Oncol Pharm Pract; 2017 Jun; 23(4):243-248. PubMed ID: 26911478
[TBL] [Abstract][Full Text] [Related]
11. Oncology pharmacy practice in a teaching hospital in Nepal.
Khanal S; Poudel A; Sharan K; Palaian S
J Oncol Pharm Pract; 2010 Jun; 16(2):75-9. PubMed ID: 19541763
[TBL] [Abstract][Full Text] [Related]
12. The need for community pharmacists in oncology outpatient care: a systematic review.
Thoma J; Zelkó R; Hankó B
Int J Clin Pharm; 2016 Aug; 38(4):855-62. PubMed ID: 27056442
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy workload benchmarking: Establishing a health-system outpatient infusion productivity metric.
Reichard JS; Garbarz DM; Teachey AL; Allgood J; Brown MJ
J Oncol Pharm Pract; 2019 Jan; 25(1):172-178. PubMed ID: 28942722
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic.
McKee M; Frei BL; Garcia A; Fike D; Soefje SA
J Oncol Pharm Pract; 2011 Dec; 17(4):387-94. PubMed ID: 21239453
[TBL] [Abstract][Full Text] [Related]
15. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
Vulaj V; Hough S; Bedard L; Farris K; Mackler E
J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
[TBL] [Abstract][Full Text] [Related]
16. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
17. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States.
Oladapo AO; Rascati KL
J Pharm Pract; 2012 Aug; 25(4):457-70. PubMed ID: 22544620
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluations of clinical pharmacy services: 2006-2010.
Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.
Al Raiisi F; Stewart D; Fernandez-Llimos F; Salgado TM; Mohamed MF; Cunningham S
Int J Clin Pharm; 2019 Jun; 41(3):630-666. PubMed ID: 30963447
[TBL] [Abstract][Full Text] [Related]
20. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
